FABTECH147.10

Fabtech Technologies Limited

· Pharma & Health
₹ CrorePeersLAXMIDENTLTARSONSFISCHERGKBMcap ₹654 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity9.149.14
Return on Assets5.875.87
Return on Capital Employed6.656.65
Return on Invested Capital6.447.09
Margins
EBITDA Margin8.528.08
Operating Margin7.237.23
Pretax Margin11.6510.94
Net Income Margin9.348.76
FCF Margin-1.03-1.03
Additional
Effective Tax Rate20.7120.59
Sustainable Growth Rate9.149.14
Incremental Operating Margin %3.94
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.